Connect with us

News

A look at when Canada could start administering COVID-19 vaccines to teens, children – Global News

Published

 on


As vaccines to protect against the novel coronavirus continue to be administered across the country, one question remains unanswered — when will shots be approved for children and when will kids be vaccinated?

On Sunday U.S. Dr. Anthony Fauci said high school students in America will “very likely be able to be vaccinated by the fall term.”

Read more:
Front-line health workers in Canada look back on ‘rollercoaster’ year of COVID-19

He said elementary school children in the U.S. would likely be ready to receive vaccinations by the first quarter of 2022 once studies on the safety of the vaccine are completed.

However, in Canada, no vaccines have been approved for use in children younger than 16 years of age.

Health Canada says it is waiting on data from the vaccine manufacturers before it approves any shot for use in children.

Story continues below advertisement

Here’s a closer look at what’s going on in Canada.

Vaccines approved

To date, Health Canada has approved four vaccines for use in Canada.

In December, the regulatory body approved two mRNA vaccines — one from Pfizer-BioNTech, the other from Moderna.

Last month, a shot from AstraZeneca was given the green light, and in early March, a shot from Johnson & Johnson was given the OK for use in Canada.

The Pfizer-BioNTech vaccine can be used in anyone 16 and older, Health Canada says, while the other three shots have been approved for adults 18 and up.


Click to play video 'Governments urge caution during spring break travel'



1:55
Governments urge caution during spring break travel


Governments urge caution during spring break travel

By Saturday morning, 2,830,586 doses of the approved COVID-19 vaccines have been administered in Canada.

Story continues below advertisement

That means approximately 3.79 per cent of the country’s population is now vaccinated against the virus.

Trials underway

Speaking to reporters earlier this month after the approval of the Johnson & Johnson vaccine, Health Canada’s chief medical advisor Dr. Supriya Sharma said a clinical trial to test the safety and efficacy of the vaccine in children aged 12 to 17 had been authorized by the agency.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

“This will be important research to support vaccine availability for all Canadians of all ages,” she said.

Sharma said the clinical trial from Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals, is the first trial Health Canada has authorized in younger adults that includes Canadian sites. It has not yet begun recruiting patients.

The other vaccine manufacturers are either looking into beginning clinical trials in children or have already started, Sharma confirmed.

“So the Pfizer and the Moderna vaccines, with respect to their clinical trials in younger-age adults — and that’s 12 to 15 for Pfizer, 12 to 17 for Moderna — have clinical trials that are ongoing, that actually finished recruiting patients into the clinical trials,” she continued. “So they’re the ones that are most far — they’re the furthest advanced in that.”

Sharma said AstraZeneca has also started a clinical trial to test its vaccine in younger age groups.

Story continues below advertisement

However, she said she expects Health Canada will receive data from Pfizer and Moderna first “because their trials in children are most advanced.”

Read more:
One year into COVID-19, a look at when and where the next pandemic could emerge

In an email to Global News, Christina Antoniou, director of corporate affairs at Pfizer Canada, said the vaccine is being studied in children aged 12-15, “and the study is ongoing.”

She said as the results of the trial become available “we will share them with Health Canada.”

“At this point, I cannot confirm when that will be,” she wrote.

However, on Thursday, Pfizer CEO Albert Bourla said he expects younger teens to be eligible for the vaccine in the fall, and elementary school students by the end of the year.

Bourla said the company plans to submit the data for children between the ages of 12 and 16 very soon.

He added that data for children aged five to 11 can be expected year-end.

Global News also reached out to Moderna to determine when exactly the data from its trial would be shared with Health Canada, but did not hear back by publication.

Timeline?

Asked by reporters whether Health Canada could approve a vaccine for use in children before school begins in the fall of 2021, Sharma said that timeline “may be a bit optimistic.”

Story continues below advertisement


Click to play video 'Montreal pediatric specialist answers questions about the coronavirus and kids'



3:46
Montreal pediatric specialist answers questions about the coronavirus and kids


Montreal pediatric specialist answers questions about the coronavirus and kids – Jan 1, 2021

“So the trials in children tend to be a bit slower to get up and running in terms of recruiting individuals,” she said. “And then, of course, we have to conduct the trials and then take that information and assess that.”

She said it’s “not inconceivable that we might have some data in the summer.”

“And potentially by the end of this calendar year, we might have some indications in children, but … that’s still pretty optimistic.”

Read more:
Young Canadians struggled most financially in 1st year of COVID-19 pandemic: Ipsos poll

She said Health Canada is not expecting results from the Jannsen clinical trial until 2022.

“So potentially by the end of the calendar year we might have some answers for children, but it really will depend on how those clinical trials are conducted and most importantly the results that we get from them,” she said.

Story continues below advertisement


Click to play video 'Health Matters: New study suggests the flu shot can protect kids from severe COVID-19'



3:19
Health Matters: New study suggests the flu shot can protect kids from severe COVID-19


Health Matters: New study suggests the flu shot can protect kids from severe COVID-19 – Feb 18, 2021

In a previous interview with Global News, Dr. Karina Top, a pediatric and infectious disease physician at IWK Health Cente in Halifax and vaccine researcher at the Canadian Centre for Vaccinology, said children are lower on the priority list for COVID-19 vaccines because they have less severe outcomes when they contract the virus, and because they have a lower transmission rate.

“Fortunately, COVID is generally or almost always a very mild disease in children,” Top told Global News.

“And young children (don’t) contribute to the spread of COVID as much as adults or older age groups,” she continued. “So for that reason, the focus has been on vaccinating the older populations and then working our way down in age groups to protect the most vulnerable.”

Read more:
Canada approves Johnson & Johnson’s 1-shot COVID-19 vaccine

Story continues below advertisement

As of Friday, a total of 152,578 cases of the novel coronavirus had been reported in those under 19 years of age.

That means approximately 16.9 per cent of Canada’s total coronavirus infections have been detected in children and teenagers.

–With files from Global News’ Marney Blunt

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

News

Canada Energy Regulator allows resumption of Trans Mountain oil project

Published

 on

The Canada Energy Regulator (CER) has issued a notice https://bit.ly/35Sm87H allowing Trans Mountain Corp to resume work on its Trans Mountain Expansion (TMX) oil pipeline project.

The company was ordered in April to halt work on a section of the project in Burnaby, British Columbia, for four months to protect hummingbird nests.

The C$12.6 billion ($10.17 billion) TMX project will nearly triple capacity of the pipeline, which runs from Edmonton in Alberta to the coast of British Columbia, to ship 890,000 barrels per day of crude and refined products when completed late 2022.

(Reporting by Arpan Varghese in Bengaluru; Editing by David Goodman)

Continue Reading

News

Senate vote opens way for single event betting

Published

 on

bar cocktail casino luck

Canada’s Senate on Tuesday passed a bill that will open the way to legalize betting on single games or sporting events, which is currently illegal except for on horse racing.

The vote sent gambling shares higher as it is seen helping them win back customers from offshore websites and U.S. casinos.

Continue Reading

News

Trudeau nominates first judge of colour to sit on Supreme Court

Published

 on

Prime Minister Justin Trudeau on Thursday made history by nominating the first judge of color to sit on the country’s Supreme Court, which has only ever had white justices in its 146-year existence.

Mahmud Jamal, who has been a judge on Ontario‘s court of appeal since 2019, trained as a lawyer and appeared before the Supreme Court in 35 appeals addressing a range of civil, constitutional, criminal and regulatory issues.

“He’ll be a valuable asset to the Supreme Court – and that’s why, today, I’m announcing his historic nomination to our country’s highest court,” Trudeau said on Twitter.

Trudeau has frequently said there is a need to address systemic racism in Canada.

Jamal, born in Nairobi in 1967, emigrated with his family to Britain in 1969 where he said he was “taunted and harassed because of my name, religion, or the color of my skin.”

In 1981 the family moved to Canada, where his “experiences exposed me to some of the challenges and aspirations of immigrants, religious minorities, and racialized persons,” he said in a document submitted to support his candidacy.

Canada is a multicultural country, with more than 22% of the population comprised of minorities and another 5% aboriginal, according to the latest census.

“We know people are facing systemic discrimination, unconscious bias and anti-black racism every single day,” Trudeau said last year.

Jamal will replace Justice Rosalie Abella, who is due to retire from the nine-person court on July 1.

 

(Reporting by David Ljunggren in Ottawa; Editing by Matthew Lewis)

Continue Reading

Trending